CVS Health Return on Tangible Equity 2010-2025 | CVS
Current and historical return on tangible equity values for CVS Health (CVS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| CVS Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $5.28B | $-40.66B | -12.28% |
| 2024-12-31 | $4.61B | $-42.87B | -10.41% |
| 2024-09-30 | $5.02B | $-43.98B | -11.26% |
| 2024-06-30 | $7.19B | $-44.47B | -15.92% |
| 2024-03-31 | $7.32B | $-45.89B | -15.87% |
| 2023-12-31 | $8.34B | $-43.87B | -18.81% |
| 2023-09-30 | $8.63B | $-46.38B | -20.95% |
| 2023-06-30 | $2.97B | $-48.38B | -7.87% |
| 2023-03-31 | $4.09B | $-38.85B | -12.27% |
| 2022-12-31 | $4.31B | $-31.18B | -13.46% |
| 2022-09-30 | $3.37B | $-32.23B | -10.41% |
| 2022-06-30 | $8.38B | $-31.19B | -25.49% |
| 2022-03-31 | $8.13B | $-33.46B | -23.86% |
| 2021-12-31 | $8.00B | $-32.77B | -22.55% |
| 2021-09-30 | $7.58B | $-34.05B | -20.19% |
| 2021-06-30 | $7.20B | $-36.07B | -18.21% |
| 2021-03-31 | $7.40B | $-39.03B | -17.81% |
| 2020-12-31 | $7.18B | $-40.99B | -16.47% |
| 2020-09-30 | $7.95B | $-42.16B | -17.48% |
| 2020-06-30 | $8.26B | $-43.93B | -17.37% |
| 2020-03-31 | $7.22B | $-47.25B | -14.57% |
| 2019-12-31 | $6.63B | $-48.70B | -12.93% |
| 2019-09-30 | $4.47B | $-50.27B | -8.38% |
| 2019-06-30 | $4.33B | $-52.05B | -9.97% |
| 2019-03-31 | $-0.17B | $-54.22B | 0.51% |
| 2018-12-31 | $-0.59B | $-56.66B | 2.58% |
| 2018-09-30 | $3.11B | $-10.76B | -24.94% |
| 2018-06-30 | $3.01B | $-11.93B | -21.58% |
| 2018-03-31 | $6.67B | $-12.83B | -43.62% |
| 2017-12-31 | $6.62B | $-14.39B | -40.05% |
| 2017-09-30 | $5.04B | $-16.60B | -30.25% |
| 2017-06-30 | $5.30B | $-17.34B | -32.15% |
| 2017-03-31 | $5.12B | $-17.81B | -31.22% |
| 2016-12-31 | $5.32B | $-14.93B | -33.41% |
| 2016-09-30 | $5.11B | $-15.83B | -32.17% |
| 2016-06-30 | $4.81B | $-17.06B | -31.50% |
| 2016-03-31 | $5.16B | $-15.83B | -46.14% |
| 2015-12-31 | $5.24B | $-14.78B | -70.30% |
| 2015-09-30 | $5.06B | $-13.46B | -135.19% |
| 2015-06-30 | $4.76B | $-0.67B | -1352.84% |
| 2015-03-31 | $4.74B | $-0.89B | -2978.62% |
| 2014-12-31 | $4.64B | $0.05B | 5495.86% |
| 2014-09-30 | $4.59B | $0.10B | 850.42% |
| 2014-06-30 | $4.89B | $0.10B | 439.36% |
| 2014-03-31 | $4.77B | $0.09B | 270.62% |
| 2013-12-31 | $4.59B | $1.87B | 207.43% |
| 2013-09-30 | $4.44B | $2.40B | 209.25% |
| 2013-06-30 | $4.20B | $2.70B | 247.46% |
| 2013-03-31 | $4.04B | $1.90B | 284.10% |
| 2012-12-31 | $3.86B | $1.51B | 275.12% |
| 2012-09-30 | $3.81B | $0.69B | 261.30% |
| 2012-06-30 | $3.68B | $1.60B | 237.94% |
| 2012-03-31 | $3.53B | $1.82B | 230.92% |
| 2011-12-31 | $3.46B | $1.72B | 202.34% |
| 2011-09-30 | $3.42B | $1.03B | 185.86% |
| 2011-06-30 | $3.36B | $1.53B | 181.32% |
| 2011-03-31 | $3.37B | $2.56B | 219.23% |
| 2010-12-31 | $3.43B | $2.25B | 384.09% |
| 2010-09-30 | $3.45B | $1.09B | 1076.23% |
| 2010-06-30 | $3.66B | $0.25B | 34083.72% |
| 2010-03-31 | $3.73B | $-0.02B | 9150.92% |
| 2009-12-31 | $3.70B | $-0.04B | -3820.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $83.088B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.306B | 27.32 |
| Elevance Health (ELV) | United States | $65.860B | 8.86 |
| Cencora (COR) | United States | $56.044B | 18.67 |
| DiDi Global (DIDIY) | China | $26.733B | 28.40 |
| Labcorp Holdings (LH) | United States | $22.380B | 17.79 |
| Natera (NTRA) | United States | $21.934B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.271B | 0.00 |
| ICON (ICLR) | Ireland | $13.654B | 13.14 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.903B | 34.15 |
| Solventum (SOLV) | United States | $12.500B | 12.90 |
| Viatris (VTRS) | United States | $11.799B | 4.20 |
| Revvity (RVTY) | United States | $10.214B | 18.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.176B | 0.00 |
| Avantor (AVTR) | United States | $8.631B | 12.66 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.258B | 0.00 |
| HealthEquity (HQY) | United States | $8.040B | 35.22 |
| Charles River Laboratories (CRL) | United States | $7.517B | 14.26 |
| Bausch + Lomb (BLCO) | Canada | $4.874B | 32.79 |
| Sotera Health (SHC) | United States | $4.221B | 23.59 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 29.35 |
| GeneDx Holdings (WGS) | United States | $3.344B | 76.59 |
| Surgery Partners (SGRY) | United States | $2.946B | 37.06 |
| Alignment Healthcare (ALHC) | United States | $2.899B | 0.00 |
| Concentras Parent (CON) | United States | $2.871B | 18.21 |
| Organon (OGN) | United States | $2.353B | 2.56 |
| Premier (PINC) | United States | $1.978B | 15.01 |
| Progyny (PGNY) | United States | $1.873B | 39.60 |
| Ardent Health (ARDT) | United States | $1.785B | 6.89 |
| PACS (PACS) | United States | $1.705B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.282B | 8.56 |
| GoodRx Holdings (GDRX) | United States | $1.250B | 20.59 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.779B | 4.56 |
| AMN Healthcare Services Inc (AMN) | United States | $0.676B | 8.36 |
| CareDx (CDNA) | United States | $0.663B | 12.22 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.08 |
| Omada Health (OMDA) | $0.497B | 0.00 | |
| So-Young (SY) | China | $0.488B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.485B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| SBC Medicals (SBC) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 25.13 |
| Agilon Health (AGL) | United States | $0.369B | 0.00 |
| Oncology Institute (TOI) | United States | $0.367B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.292B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.169B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |